Federal Register / Vol. 66, No. 100 / Wednesday, May 23, 2001 / Notices 28533

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS

Dated: May 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12920 Filed 5–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Allergy and Infectious Disease Special

Emphasis Panel.

Date: June 12, 2001.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 6700 B Rockledge Drive, Bethesda,

MD 20892 (Telephone Conference Call).

Contact Person: Nasrin Nabavi, Ph.D.,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Room 2156, 6700B

Rockledge Drive, MSC 7610, Bethesda, MD

20892–7610, 301 496–2550, nn30t@nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,

and Transplantation Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: May 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12921 Filed 5–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institutes of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant application and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institutes of

Allergy and Infectious Diseases Special

Emphasis Panel ‘‘Peripheral Tolerance and

Autoimmunity.’’

Date: June 13, 2001.

Time: 1 p.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: 6700 B Rockledge Drive, Room 2223,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Nasrin Nabavi, PhD,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Room 2156, 6700B

Rockledge Drive, MSC 7610, Bethesda, MD

20892–7610, 301 496–2550, nn30t@nih.gov.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,

and Transplantation Research; 93856,

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: May 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12922 Filed 5–22–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Alcohol Abuse

and Alcoholism; Notice of Closed

Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel

Date: May 23, 2001.

Time: 10 am to 5 pm.

Agenda: To review and evaluate contract

proposals.

Place: 6000 Executive Blvd., Suite 400,

Rockville, MD 20852.

Contact Person: Sean O’Rourke, Scientific

Review Administrator, Extramural Project

Review Branch, National Institute on Alcohol

Abuse and Alcoholism, National Institutes of

Health, Suite 409, 6000 Executive Boulevard,

Bethesda, MD 20892–7003, 301–443–2861.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Alcohol Abuse and Alcoholism Special

Emphasis Panel.

Date: June 18, 2001.

Time: 8:30 am to 4 pm.

Agenda: To review and evaluate contract

proposals.

Place: 6000 Executive Boulevard, Suite

409, Rockville, MD 20852, (Telephone

Conference Call).

Contact Person: Ronald Suddendorf, PhD,

Scientific Review Administrator, Extramural

Project Review Branch, National Institute on

Alcohol Abuse and Alcoholism, National

Institutes of Health, Suite 409, 6000

Executive Boulevard, Bethesda, MD 20892–

7003, 301–443–2926.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.271, Alcohol Research

Career Development Awards for Scientists

and Clinicians; 93.272, Alcohol National

Research Service Awards for Research

Training; 93.273, Alcohol Research Programs;

93.891, Alcohol Research Center Grants,

National Institutes of Health, HHS)

Dated: May 16, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–12927 Filed 5–22–01; 8:45 am]

BILLING CODE 4140–01–M